Avandia prescriptions have plummeted since a study in The New England Journal of Medicine in May 2007 raised concerns about whether the drug increased heart attack risk.
In June 2007, 5.6 million Avandia prescriptions were dispensed in the USA, according to IMS Health, which provides market information to the drug and health care industries. By May 2010, that number had dropped to 1 million.
Mayo Clinic endocrinologist Victor Montori, who wasn't an FDA panelist, says fewer than 10% of U.S. diabetes patients still take the drug. "If the FDA does not do anything, I think the market will continue to shrink," he says.
via usatoday.com
No comments:
Post a Comment